HCW Biologics Inc.
HCWB· Nasdaq
HCWBHCW Biologics Inc.
Filed May 13, 2022 · 10-Q · 43 days after period end · 0000950170-22-009794
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | $3.12M | $0.00 | — |
| Net Income | -$2.06M | -$2.84M | -$2.38M |
| EPS Diluted | -$0.06 | -$0.69 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
HCW Biologics Inc. · CIK 1828673 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 13, 2022 · 43 d after period end
